Cancel
See Linkedin
Known information
- Holds a Ph.D. in computational chemistry from Uppsala University
- Earned a Master of Science in integrative pharmacology from Gothenburg University
- Completed an MBA from the MIT Sloan School of Management
- Previously built and led Pfizer's systems immunology function
- Served as executive director of clinical programs at Pfizer, launching several Phase 2 studies across autoimmune indications
- Co-founded Elsa.science, a digital health company in the rheumatoid arthritis space
- Serves on the board of the Swedish New England Chamber of Commerce
- Was CEO of BioChromix Pharma before moving to the US in 2013
- Began her career at AstraZeneca as Project Director, Global In Vitro Metabolism Leader and Computational Chemist
- Named to the PharmaVoice 100 list of life science industry leaders in 2023
- Included in the top 100 'most influential persons under age 40 in Sweden' by Affärsvärlden
- Received the Rosenön Award for best thesis of the year within the field of pharmacodynamics/pharmacokinetics in Sweden
About Alltrna
Alltrna is the world's first tRNA platform company, pioneering tRNA therapeutics to potentially treat thousands of diseases by targeting premature stop codons.
Report inaccurate information
